🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Celemics Inc (331920)

KOSDAQ
Currency in KRW
3,330
+230(+7.42%)
Closed
331920 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
3,1303,330
52 wk Range
2,80510,400
Key Statistics
Edit
Bid/Ask
3,310.00 / 3,330.00
Prev. Close
3,100
Open
3,130
Day's Range
3,130-3,330
52 wk Range
2,805-10,400
Volume
51.39K
Average Volume (3m)
71.26K
1-Year Change
-9.95%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
331920 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple
Show more

Celemics Inc Company Profile

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development services. Its products are used in oncology, liquid biopsy, biopharma solutions, inherited diseases, pharmacogenomics, virus research, agrigenomics, RNA sequencing, epigenetics, metagenomic sequencing, antibody discovery, and bioinformatics applications. The company was founded in 2010 and is headquartered in Seoul, South Korea.

Compare 331920 to Peers and Sector

Metrics to compare
331920
Peers
Sector
Relationship
P/E Ratio
1.2x−2.6x−0.7x
PEG Ratio
-0.010.00
Price/Book
0.7x1.4x2.6x
Price / LTM Sales
4.5x3.1x3.2x
Upside (Analyst Target)
-45.6%47.1%
Fair Value Upside
Unlock9.4%7.3%Unlock

FAQ

What Is the Celemics (331920) Stock Price Today?

The Celemics stock price today is 3,330.00

What Stock Exchange Does Celemics Trade On?

Celemics is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Celemics?

The stock symbol for Celemics is "331920."

What Is the Celemics Market Cap?

As of today, Celemics market cap is 23.27B.

What is Celemics Earnings Per Share?

The Celemics EPS is 2,683.13.

From a Technical Analysis Perspective, Is 331920 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.